Critical Role of Histamine H4 Receptor in Leukotriene B 4 Production and Mast Cell-Dependent Neutrophil Recruitment Induced by Zymosan in Vivo

Journal of Pharmacology and Experimental Therapeutics

Volumn 307, Issue 3, 2003, Pages 1072-1078

  Takeshita, Keisuke ^a   Sakai, Katsuya ^a   Bacon, Kevin B ^a   Gantner, Florian ^a  

^a BAYER YAKUHIN LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CARRAGEENAN; CHEMOATTRACTANT; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HISTAMINE H3 RECEPTOR ANTAGONIST; HISTAMINE H4 RECEPTOR; LEUKOTRIENE B4; MYELOID DIFFERENTIATION FACTOR 88; RECEPTOR ANTIBODY; RECEPTOR PROTEIN; THIOPERAMIDE; TOLL LIKE RECEPTOR 2; ZYMOSAN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MAST CELL; MOUSE; MOUSE STRAIN; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIA; NONHUMAN; PLEURA CAVITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; CARRAGEENAN; CIMETIDINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTAMINE ANTAGONISTS; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HISTAMINE RELEASE; LEUKOTRIENE B4; MAST CELLS; MICE; MICE, INBRED BALB C; NEUTROPHIL INFILTRATION; PIPERIDINES; PLEURISY; PYRILAMINE; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; RECEPTORS, HISTAMINE H3; ZYMOSAN;

EID: 0345167199     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.057489     Document Type: Article

References (31)

1. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, and Akira S (1998) Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9:143-150.
2. Bakker RA, Timmerman H, and Leurs R (2002) Histamine receptors: specific ligands, receptor biochemistry and signal transduction. Clin Allergy Immunol 17: 27-64.
3. Barnes PJ, Chung KF, and Page CP (1998) Inflammatory mediators of asthma: an update. Pharmacol Rev 50:515-596.
4. Barocelli E and Ballabeni V (2003) Histamine in the control of gastric acid secretion: a topic review. Pharmacol Res 47:299-304.
5. Byrum RS, Goulet JL, Snouwaert JN, Griffiths RJ, and Koller BH (1999) Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase- and leukotriene A4 hydrolase-deficient mice. J Immunol 163:6810-6819.
6. Coge F, Guenin SP, Rique H, Boutin JA, and Galizzi JP (2001) Structure and expression of the human histamine H4-receptor gene. Biochem Biophys Res Commun 284:301-309.
7. Damas J and Remacle-Volon G (1986) Mast cell amines and the oedema induced by zymosan and carrageenans in rats. Eur J Pharmacol 121:367-376.
8. Gantner F, Sakai K, Tusche MW, Cruikshank WW, Center DM, and Bacon KB (2002) Histamine h(4) and h(2) receptors control histamine-induced interleukin-16 release from human CD8(+) T cells. J Pharmacol Exp Ther 303:300-307.
9. Haribabu B, Verghese MW, Steeber DA, Sellars DD, Bock CB, and Snyderman R (2000) Targeted disruption of the leukotriene B(4) receptor in mice reveals its role in inflammation and platelet-activating factor-induced anaphylaxis. J Exp Med 192:433-438.
10. Hill SJ, Ganellin CR, Timmerman H, Schwartz JC, Shankley NP, Young JM, Schunack W, Levi R, and Haas HL (1997) International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev 49:253-278.
11. Hofstra CL, Desai PJ, Thurmond RL, and Fung-Leung WP (2003) Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J Pharmacol Exp Ther 305:1212-1221.
12. Horakova Z, Bayer BM, Almeida AP, and Beaven MA (1980) Evidence that histamine does not participate in carrageenan-induced pleurisy in rat. Eur J Pharmacol 62:17-25.
13. Hough LB (2001) Genomics meets histamine receptors: new subtypes, new receptors. Mol Pharmacol 59:415-419.
14. Jutel M, Watanabe T, Akdis M, Blaser K, and Akdis CA (2002) Immune regulation by histamine. Curr Opin Immunol 14:735-740.
15. Koarai A, Ichinose M, Ishigaki-Suzuki S, Yamagata S, Sugiura H, Sakurai E, Makabe-Kobayashi Y, Kuramasu A, Watanabe T, Shirato K, et al. (2003) Disruption of L-histidine decarboxylase reduces airway eosinophilia but not hyperresponsiveness. Am J Respir Crit Care Med 167:758-763.
16. Kolaczkowska E (2002) Shedding light on vascular permeability during peritonitis: role of mast cell histamine versus macrophage cysteinyl leukotrienes. Inflamm Res 51:519-521.
17. Kolaczkowska E, Seljelid R, and Plytycz B (2001a) Critical role of mast cells in morphine-mediated impairment of zymosan-induced peritonitis in mice. Inflamm Res 50:415-421.
18. Kolaczkowska E, Seljelid R, and Plytycz B (2001b) Role of mast cells in zymosan-induced peritoneal inflammation in Balb/c and mast cell-deficient WBB6F1 mice. J Leukoc Biol 69:33-42.
19. Liu C, Ma X, Jiang X, Wilson SJ, Hofstra CL, Blevitt J, Pyati J, Li X, Chai W, Carruthers N, et al. (2001) Cloning and pharmacological characterization of a fourth histamine receptor (H(4)) expressed in bone marrow. Mol Pharmacol 59: 420-426.
20. Lo TN, Almeida AP, and Beaven MA (1982) Dextran and carrageenan evoke different inflammatory responses in rat with respect to composition of infiltrates and effect of indomethacin. J Pharmacol Exp Ther 221:261-267.
21. Morse KL, Behan J, Laz TM, West RE Jr, Greenfeder SA, Anthes JC, Umland S, Wan Y, Hipkin RW, Gonsiorek W, et al. (2001) Cloning and characterization of a novel human histamine receptor. J Pharmacol Exp Ther 296:1058-1066.
22. Nakamura T, Itadani H, Hidaka Y, Ohta M, and Tanaka K (2000) Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem Biophys Res Commun 279:615-620.
23. Nguyen T, Shapiro DA, George SR, Setola V, Lee DK, Cheng R, Rauser L, Lee SP, Lynch KR, Roth BL, et al. (2001) Discovery of a novel member of the histamine receptor family. Mol Pharmacol 59:427-433.
24. Oda T, Morikawa N, Saito Y, Masuho Y, and Matsumoto S (2000) Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes. J Biol Chem 275:36781-36786.
25. O'Reilly M, Alpert R, Jenkinson S, Gladue RP, Foo S, Trim S, Peter B, Trevethick M, and Fidock M (2002) Identification of a histamine H4 receptor on human eosinophil-role in eosinophil chemotaxis. J Recept Signal Transduct Res 22:431-448.
26. Rao TS, Currie JL, Shaffer AF, and Isakson PC (1994) In vivo characterization of zymosan-induced mouse peritoneal inflammation. J Pharmacol Exp Ther 269: 917-925.
27. Repka-Ramirez MS and Baraniuk JN (2002) Histamine in health and disease. Clin Allergy Immunol 17:1-25.
28. Schneider E, Rolli-Derkinderen M, Arock M, and Dy M (2002) Trends in histamine research: new functions during immune responses and hematopoiesis. Trends Immunol 23:255-263.
29. Tarayre JP, Delhon A, Aliaga M, Barbara M, Bruniquel F, Caillol V, Puech L, Consul N, and Tisne-Versailles J (1989) Pharmacological studies on zymosan inflammation in rats and mice. 2: Zymosan-induced pleurisy in rats. Pharmacol Res 21:385-395.
30. Winbery SL and Lieberman PL (2002) Histamine and antihistamines in anaphylaxis. Clin Allergy Immunol 17:287-317.
31. Zhu Y, Michalovich D, Wu H, Tan KB, Dytko GM, Mannan IJ, Boyce R, Alston J, Tierney LA, Li X, et al. (2001) Cloning, expression and pharmacological characterization of a novel human histamine receptor. Mol Pharmacol 59:434-441.